ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04115	p53 signaling pathway	3/4	74/7206	4.12878779406e-06
ko05206	MicroRNAs in cancer	3/4	177/7206	5.72455284021e-05
ko05219	Bladder cancer	2/4	48/7206	0.000258498196994
ko01524	Platinum drug resistance	2/4	76/7206	0.000649727928128
ko05214	Glioma	2/4	79/7206	0.000701997779412
ko05220	Chronic myeloid leukemia	2/4	85/7206	0.000812506433834
ko05218	Melanoma	2/4	85/7206	0.000812506433834
ko05215	Prostate cancer	2/4	111/7206	0.00138273168527
ko01522	Endocrine resistance	2/4	124/7206	0.00172303540505
ko04919	Thyroid hormone signaling pathway	2/4	143/7206	0.0022858518377
ko04110	Cell cycle	2/4	145/7206	0.00234958713116
ko04218	Cellular senescence	2/4	177/7206	0.00348450605368
ko05202	Transcriptional misregulation in cancer	2/4	188/7206	0.00392425695971
ko05169	Epstein-Barr virus infection	2/4	206/7206	0.0046979565878
ko05205	Proteoglycans in cancer	2/4	271/7206	0.0080407088295
ko05203	Viral carcinogenesis	2/4	277/7206	0.00839183641541
ko04151	PI3K-Akt signaling pathway	2/4	390/7206	0.0162985750093
ko05216	Thyroid cancer	1/4	34/7206	0.0187438818745
ko04216	Ferroptosis	1/4	44/7206	0.0242062923385
ko00970	Aminoacyl-tRNA biosynthesis	1/4	44/7206	0.0242062923385
ko05200	Pathways in cancer	2/4	492/7206	0.0254497024399
ko05213	Endometrial cancer	1/4	62/7206	0.0339811229605
ko05223	Non-small cell lung cancer	1/4	66/7206	0.036143296333
ko05217	Basal cell carcinoma	1/4	68/7206	0.0372230209095
ko05014	Amyotrophic lateral sclerosis (ALS)	1/4	74/7206	0.0404567523021
ko05230	Central carbon metabolism in cancer	1/4	81/7206	0.044219135619
ko04137	Mitophagy - animal	1/4	82/7206	0.0447557143494
ko05212	Pancreatic cancer	1/4	83/7206	0.0452920671213
ko05210	Colorectal cancer	1/4	86/7206	0.0468997703113
ko05222	Small cell lung cancer	1/4	89/7206	0.0485054421488